Key facts
- This page summarizes Olivier Danos's Form 4 filing for REGENXBIO Inc. (RGNX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2025, 16:59.
Olivier Danos - 02 Jan 2025 Form 4 Insider Report for REGENXBIO Inc. (RGNX)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- RGNX
- Reported as of
- 02 Jan 2025
- Net transaction value
- -$97,630
- SEC form
- 4
- Accepted by SEC
- 06 Jan 2025, 16:59:30 UTC
- Prior SEC filing
- 05 Aug 2024
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick J. Christmas as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Olivier Danos filed Form 4 for REGENXBIO Inc. (RGNX) on 06 Jan 2025.
Change
- Previous filing in this sequence was filed on 05 Aug 2024.
- Current net transaction value: -$97,630.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RGNX
transaction
Common Stock
Tax liability
- Transaction value
- $97,630
- Shares
- -12,630
- Change %
- -6.8%
- Price
- $7.73
- Shares after
- 172,453
- Date
- 02 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
RGNX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +59,347
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 231,800
- Date
- 02 Jan 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RGNX
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +95,721
- Change %
- Price
- $0.000000
- Shares after
- 95,721
- Date
- 02 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 95,721
- Exercise price
- $7.86
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024.
Footnote F2
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer.
Footnote F3
25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.